PROSTATE CANCER Time for active surveillance of intermediate-risk disease?

被引：7
|
作者：
Ahmed, Hashim U. [1 ]
机构：
[1] UCL, Div Surg & Intervent Sci, London WC1E 6AU, England
来源：
NATURE REVIEWS UROLOGY | 2013年 / 10卷 / 01期
基金：
英国医学研究理事会;
关键词：
MANAGEMENT;
D O I：
10.1038/nrurol.2012.213
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Active surveillance has become increasingly popular as a management option for localized prostate cancer. Although widely viewed as a means to enable men with low-risk prostate cancer to avoid or defer the effects of whole-gland radical therapy, two new studies demonstrate that it might be a safe approach in intermediate-risk disease. Ahmed, H. U. Nat. Rev. Urol. 10, 6-8 (2013); published online 13 November 2012; doi:10.1038/nrurol.2012.213
引用
收藏
页码：6 / 8
页数：4
相关论文
共 50 条
  • [1] Active surveillance in intermediate-risk prostate cancer
    Klotz, Laurence
    [J]. BJU INTERNATIONAL, 2020, 125 (03) : 346 - 354
  • [2] Active surveillance for intermediate-risk prostate cancer
    M A Dall'Era
    L Klotz
    [J]. Prostate Cancer and Prostatic Diseases, 2017, 20 : 1 - 6
  • [3] Active surveillance for intermediate-risk prostate cancer
    Dall'Era, M. A.
    Klotz, L.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (01) : 1 - 6
  • [4] Active surveillance for intermediate-risk prostate cancer
    Nayan, Madhur
    Carvalho, Filipe L. F.
    Feldman, Adam S.
    [J]. WORLD JOURNAL OF UROLOGY, 2022, 40 (01) : 79 - 86
  • [5] Active surveillance for intermediate-risk prostate cancer
    Madhur Nayan
    Filipe L. F. Carvalho
    Adam S. Feldman
    [J]. World Journal of Urology, 2022, 40 : 79 - 86
  • [6] Time for active surveillance of intermediate-risk disease?
    Hashim U. Ahmed
    [J]. Nature Reviews Urology, 2013, 10 : 6 - 8
  • [7] Is active surveillance safe for patients with intermediate-risk prostate cancer?
    Chung, Hoseok
    Shin, Bo Sung
    Nam, Deok-Hyun
    Chung, Hoseok
    Kim, Myung Ki
    Jung, Seung Il
    Kang, Taek Won
    Kwon, Dong Deuk
    [J]. BJU INTERNATIONAL, 2015, 116 : 4 - 4
  • [8] Active surveillance for intermediate-risk prostate cancer: yes, but for whom?
    Overland, Maya R.
    Washington, Samuel L., III
    Carroll, Peter R.
    Cooperberg, Matthew R.
    Herlemann, Annika
    [J]. CURRENT OPINION IN UROLOGY, 2019, 29 (06) : 605 - 611
  • [9] Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Diven, Marshall A.
    Tshering, Lhaden
    Ma, Xiaoyue
    Hu, Jim C.
    Barbieri, Christopher
    McClure, Timothy
    Nagar, Himanshu
    [J]. JAMA NETWORK OPEN, 2024, 7 (08)
  • [10] Outcomes for Men with Intermediate-risk Prostate Cancer on Active Surveillance
    Courtney, P. T.
    Deka, R.
    Cherry, D. R.
    Nelson, T. J.
    Luterstein, E.
    Salans, M. A.
    Yip, A. T. T.
    Nalawade, V.
    Parsons, J. K.
    Kader, K.
    Stewart, T. F.
    Rose, B. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S121 - S122
12345